Bone fragility in mastocytosis: Clinical insights from a 5-patient retrospective case series
{{output}}
ObjectiveThis retrospective case series aimed to describe 36-month skeletal, biochemical, safety, and patient-reported outcomes in five postmenopausal women with mastocytosis treated with denosumab.MethodsA technical expert panel (TEP) retrospectively evaluate... ...
